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ABSTRACT 
Isoteoline, a compound of aporphine structure, was studied for antidepressant activity. Two animal models 
were used: the behavioral despair test and the clonidine-induced hypothermia. Isoteoline failed to alter the 
immobility time in rats subjected to forced swimming, but antagonized the immobility-reducing effect of 
desipramine, both after a single and multiple administration. In rats made hypothermic by i.p. injection of 
clonidine, Isoteoline did not antagonize the effect on rectal temperature, but rather accentuated it. The con­
clusion was made that Isoteoline was devoid of antidepressant activity. The results were analyzed in terms of 
previously demonstrated interactions of Isoteoline with subtypes of serotonergic receptors and were found to 
provide further evidence in support of these interactions. 
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INTRODUCTION 
Isoteoline (1ST) is a compound of aporphine structure de­
rived from the alkaloid glaucine. It has been shown to pos­
sess cardiovascular and central nervous system effects, the 
most prominent of which being the blood pressure lowering 
(3) and the anxiolytic (2,19) ones. The vascular effects are 
believed to be of adrenergic and/or dopaminergic nature. 
The anxiolytic effect o f 1ST demonstrated on rats and mice 
is probably mediated by 5-HT2 receptor antagonism, possi­
bly o f the 5 -HT2C subtype. 1ST has been shown to behave 
as a 5 -HT2C antagonist in a number o f experimental mod­
els (2,18,20). It has been also found to act in a 5 -HT1B 
agonistic manner in a specific test (unpublished data). 
The 5 -HT neurotransmission is well recognized to play a 
role in the mechanism of action of different groups of anti­
depressants. With many of them, along with the leading 
mechanism of reuptake inhibition o f 5 -HT and/or 
noradrenalin, a direct interaction with 5 -HT receptors has 
been found (9,14). It is not known i f this is a major mecha­
nism, or it merely contributes to the additional characteris­
tics of the drugs. 
Taking into consideration the interaction of 1ST with the 
serotonergic neurotransmission, the present study was un­
dertaken to test 1ST for antidepressant activity. For this pur­
pose we utilized two experimental models, used routinely 
for screening of antidepressant drugs: the behavioral de-
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spair test o f Porsolt (13) and the clonidine-induced hypo­
thermia test (6) . 
M A T E R I A L AND METHODS 
Animals. Male Wistar rats o f 160-185g mean body weight 
were used. The animals were kept under the standard con­
ditions of the animal house, with 12:12 h light-dark cycle 
and lights on at 7:00 a.m. The animals had free access to 
food and water. 
Drugs. Isoteoline hydrobromide was synthesized at the De­
partment of Phannacology of the Higher Medical Institute 
in Varna (the identity of 1ST was checked by means of 
H P L C analysis by comparing the compound with an 
auhentic sample and its purity was 98% (1). Desipramine 
( D M I ) was used in the form of the commercial preparation 
Petylyl (Germed). Clonidine hydrochloride was purchased 
from Sigma. 
Behavioral despair test (forced swimming test). 
The animals were placed into a glass cylinder filled with 
water (of temperature 25°C) up to 18cm in height. After the 
first burst of active movements in seeking a way out, the an­
imals stop fighting and acquire a passive posture, keeping 
their nose above the water only by slight supportive move­
ments. This immobility is regarded as an index o f behav­
ioral despair, that is, as a reaction of the animals to an ines­
capable stress situation. The time in which the rats remain 
in this position is the quantifiable criterion of this 'desper­
ate' condition. 
The immobility time was measured during 5min sessions. 
1ST was used intraperitoneally (i.p.) at doses of 0.25, 1 and 
4mg/kg. The treatment of 1ST was given either acutely 60 
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min prior to test or repeatedly. In the latter case, 1ST was 
injected twice daily over three consecutive days and the test 
was performed 16h after the last injection. In addition to be­
ing given on its own, 1ST was also administered in combi­
nation with D M I , which was used as a reference drug. D M I 
(lOmg/kg) was injected i.p. 60min before the test or 60min 
after the administration o f 1ST and was also given as a sin­
gle or multiple (of the same duration) treatment. 
D M I given i.p at I Omg/kg 60min before the start of the test, 
lead to a statistically significant decrease of the immobility 
time: 156 ±9.8sec (n=10) vs. control values of 202 ±16.8 
sec (n = 12) (p =0.0364). 
Multiple (2x3 days) administration o f D M I resulted in 138 
± 15 sec (n =6) vs. 208 ±20 sec (n =6) for the control ani­
mals (p =0.0188) (Fig. 2) . 
Clonidine-induced hypothermia. 
The rectal temperature of the rats was measured by means 
of a transistor thermoresistant thermometer, made in the 
laboratory for medicinal instruments in the Higher Medical 
Institute o f Plovdiv, Bulgaria. The lubricated themio-
electrode was inserted into the rectum at a depth of 3cm. 
The measurements were taken at an ambient temperature of 
an average o f 20°C. 
The initial rectal temperature was read twice before the ap­
plication of the drugs at an interval o f 60min. The tempera­
tures were measured at the 60 t h , 90 f l l, 120 d l, 150fl l, 210 d l , 
240 d l min after the injection of the pharmacological agent. 
1ST (0.25, 1 and 4mg/kg) was given i.p. on its own, or 
30min before clonidine (0.2mg/kg, i.p.). For a better com­
parability, the results are represented as absolute differences 
between the mean initial temperature and the temperature 
taken after each of the treatments. 
Statistics. The results are represented as a mean ± S E M . The 
statistical assessment of the data was perfomied by means 
of one way A N O V A , followed by Dunnetfs multiple com­
parison test. T w o separate groups were compared by means 
of Student's /-test. GraphPad Prism software packet was 
used. 
RESULTS AND DISCUSSION 
Effect of 1ST on the behavioral despair test 
With both regimens of application - acute or multiple, 1ST 
alone had no effect on the immobility time of rats subjected 
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Fig. 2. Effect of DMI on immobility time of rats in the 
test of behavioral despair 
The pretreatment with 1ST reduced the effect of D M I both 
with acute and multiple treatment. The single administra­
tion of 1ST resulted in immobility time o f 214 ±10.3 sec 
(n=l I ) at 0.25mg/kg, 200 ± 16.5 sec (n= 11) at Img/kg, and 
190 ±18 sec ( n = l l ) at 4mg/kg (one way A N O V A , 
p=0.0486; Dunnetfs multiple comparison test, p<0.05 for 
1ST 0.25mg/kg). With multiple administration of 1ST the 
results were: 128 ±17 sec (n=6) at 0.25mg/kg, 160 ±18sec 
(n=4) at 1 mg/kg, and 224 ±22 sec (n=4) at 4mg/kg (one 
way A N O V A , p=0.0096; Dunnett's multiple comparison 
test, p<0.05 for 1ST 4mg/kg) (Fig . 3). 
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Fig. I . Effect of 1ST on immobility time of rats in the test 
of behavioral despair 
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Fig. 3. Effect of 1ST on the anti-immobility effect of DMI 
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:/ of 1ST on clonidine-induced hypothermia 
Clonidine (0.2mg/kg) caused a marked decrease in the rats" 
rectal temperature with a trough of about -2°C at the 
120 , 1 ,min. The 30min pre-treatment with 1ST accentuated 
the effect o f clonidine in an inverted dose-dependent man­
ner, the smallest dose (0.25mg/kg) being the most effective. 
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Fig. 4A. Effect of 1ST on clonidine-induced 
hypothermia. Time-effect of 1ST throughout the 
At the 210 t h min clonidine induced a temperature drop of 
-2.07 ±0.34°C (n=7), and the pretreatmet with 1ST deep­
ened this effect to -3.73 ±0.41 °C with 0.25mg/kg (n=6), to 
-3.05 ±0.31°C with !mg/kg (n=6), and to -2.45 ±0.26°C 
with 4mg/kg (one way A N O V A , p=0.0112; Dunnett's 
multiple comparison test, pO .Ol for 1ST 0.25mg/kg) (Fig. 
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Fig. 4B. Effect of 1ST on clonidine-induced hypothermia 
at the 120°' min (the time of maximal effect of clonidine) 
Interaction with serotonergic and other receptors has been 
described with different antidepressants. One mechanism 
of this interaction is 5-HT2 receptor antagonism found with 
representatives o f the tricyclic, selective serotonin reuptake 
inhibitors and atypical group (14). Some azapirones are 
agonists at 5 - H T I A receptors and display antidepressant 
activity, at least in experimental conditions, in addition to 
their clinically useful anxiolytic activity (9) . 
Our interest to study 1ST for potential antidepressant activ­
ity was dictated by the findings of antagonistic behavior of 
1ST at 5 -HT2C receptors and the data o f 5-HT1В some ag­
onist-like effects. 
The model described by Porsolt is one of the commonly 
used tests to study antidepressant drugs (13). Many of the 
clinically used antidepressants give positive results in this 
test. They typically reduce the immobility time, during 
which the animals, forced to swim, cease to actively search 
for escape and acquire an immobile position. 1ST was 
tested on rats treated acutely and sub-acutely (for three 
days). With both treatments 1ST was devoid of any effect 
on immobility time. A s opposed to 1ST, D M I used as a pos­
itive control decreased the immobility time after a single 
and multiple administration, through increasing the time 
spent in fighting. When 1ST pre-treatment was given to 
DMI-treated animals, the anti-immobility effect of D M I 
was reduced. The effect was of similar magnitude with the 
three doses used, but only with the smallest one 
(0.25mg/kg) were the results statistically significant. After 
multiple treatment the effect of 1ST was dose-dependent 
with significant antagonism reached at 4mg/kg. The differ­
ent dose-effect relationship of 1ST according to the duration 
of treatment may reflect some tolerance developing during 
the course of longer administration. 
Different explanations of the present effect of 1ST are possi­
ble: 
According to Espejo and Minano (7), the depression-like 
symptoms in the forced swimming of rats are due to the en­
hanced dopaminergic brain activity. Suhara et al. (15) have 
found that D M I inhibits the effects o f dopamine probably 
by reducing its receptor binding. This would mean that acti­
vating dopaminergic activity would antagonize the effect of 
D M I . 1ST could activate dopaminergic activity in two pos­
sible ways: 
1. There is evidence suggesting a tonic inhibition of 
dopaminergic neurotransmission by 5 -HT2C stimulation 
(10,11). Correspondingly, the 5 -HT2C antagonist 
SB-242084 has been found to increase the dopamine level 
in a dialysate from frontal cortex (10). Being a putative 
5 -HT2C receptor antagonist, 1ST could have similar effects 
and this might account for its effects found in the present 
study. 
2. A direct dopaminomimetic action o f 1ST itself cannot be 
ruled out (17). 
Cervo et al. (4) reported inhibition o f the D M I 
anti-immobility effect by serotonin agonists and found this 
effect to be dependent on 5-HT1В receptor stimulation. B y 
analogy, we could assume the same mechanism for 1ST, 
based on the ability of 1ST to behave as a 5-HT1В agonist 
in a specific experimental set (personal unpublished data). 
Theoretically, yet another option exists to explain the effect 
o f 1ST. Kitada et al. (8) have demonstrated that the 
anti-immobility effect o f D M I can be prevented by al-
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pha-adrenergic blockers. Data exist that boldine (an isomer 
of 1ST) and other closely related aporphine derivatives dis­
play alpha-adrenolytic activity (16). 1ST could behave simi­
larly, as evidenced by its blood pressure reducing proper­
ties. However, 1ST was found to be ineffective in inducing 
ptosis in rats as an index of alpha-adrenolytic function, 
which makes the possibility o f 1ST acting as an al-
pha-blocker to prevent the effect of D M I unlikely. 
Altogether, various factors should be taken into account 
when looking for interpretation o f the anti-DMl effect of 
1ST in the rat behavioral despair test. 
Most probably a complex mechanism involving interaction 
w ith different receptors for serotonin and/or dopamine un­
derlies the modifying effect of 1ST in respect to the DM1 ac­
tion. 
Clonidine hypothermia represents another model for anti­
depressant screening (6) . Antagonism to this effect of 
clonidine correlates with antidepressant activity. 1ST was 
ineffective in reversing the hypothermia induced by 
clonidine in agreement with the negative results from the 
forced swimming test. Moreover, an enhancement of 
clonidine hypothemiia was found. This finding was intrigu­
ing and stimulated our search for an explanation. Data from 
the literature show an existence o f serotonergic component 
in the hypothennia caused by clonidine (12). 
The authors have found that this hypothermic effect was in­
creased at the background of serotonin depletion by 
chlorophenylalanine or with destruction of the median 
raphe nucleus; it was reduced by indirect (fenfluramine) or 
direct (chlorophenylpiperazine) 5 - H T agonists. The present 
effect of 1ST is similar to that of the factors reducing the 
serotonergic activity. Having in mind the 5 -HT2C antago­
nist action o f 1ST and the fact that most effects of 
chlorophenylpiperazine are mediated through the same re­
ceptors (5). the augmentation of clonidine hypothennia by 
1ST may serve another indirect piece of evidence favoring 
antagonism at the 5 -HT2C receptors. A puzzling moment 
in the present results is the inverse dose-effect relationship 
of 1ST. The smallest dose was the most active. It is possible 
that the selectivity o f the effect is lost with higher doses due 
to interference of other mechanisms. 
CONCLUSION 
The results from the present study demonstrate that 1ST is 
devoid of antidepressant activity in the tests used. At the 
same time they provide further, albeit indirect, evidence 
pointing at interaction o f 1ST with central serotonergic re­
ceptors of 5 -HT2C and/or, probably, 5 -HT 1В subtype. 
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